Oramed Pharmaceuticals Inc. SEC filings ORMP

Oramed Pharmaceuticals Inc. has 941 filings in SEC EDGAR's recent list, going back to Nov 29, 2002. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Oramed Pharmaceuticals Inc. SEC filings
Form Description Filed Period
8-K Current report
Shareholder vote results
Sep 17, 2026 Sep 15, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
ARS Annual report to shareholders Aug 3, 2026 Dec 31, 2025
DEFA14A Additional proxy material Aug 3, 2026 —
DEF 14A Proxy statement Aug 3, 2026 Sep 15, 2026
8-K Current report
Bylaw or fiscal year change, Other events
Jun 30, 2026 Jun 25, 2026
10-Q Quarterly report May 19, 2026 Mar 31, 2026
NT 10-Q Notification of late filing May 15, 2026 Mar 31, 2026
8-K Current report
Material agreement, Acquisition or sale of assets
Mar 31, 2026 Mar 25, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Material agreement
Feb 20, 2026 Feb 19, 2026
8-K Current report
Material agreement, Other events
Jan 14, 2026 Jan 12, 2026
8-K Current report
Other events
Jan 7, 2026 Jan 7, 2026
8-K Current report
Officer or director change
Dec 31, 2025 Dec 31, 2025
8-K Current report
Other events
Dec 31, 2025 Dec 30, 2025
8-K Current report
Results of operations
Nov 17, 2025 Nov 17, 2025
8-A12B For registration of certain classes Nov 17, 2025 —
8-K Current report
Material agreement, Change to shareholder rights
Nov 17, 2025 Nov 16, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Material agreement, Agreement ended, Results of operations, Other events
Oct 24, 2025 Oct 20, 2025
8-K Current report
Other events
Oct 6, 2025 Sep 30, 2025
S-8 Employee stock plan registration Aug 21, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Aug 21, 2025 Aug 19, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Material agreement, Other events
Jul 23, 2025 Jul 22, 2025
ARS Annual report to shareholders Jul 16, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 16, 2025 Aug 19, 2025
10-K/A Amended annual report Jul 16, 2025 Dec 31, 2024
8-K Current report
Other events
May 21, 2025 May 21, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Apr 28, 2025 Apr 24, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Material agreement
Mar 3, 2025 Feb 28, 2025
8-K Current report
Material agreement
Feb 27, 2025 Feb 22, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Feb 11, 2025 Feb 7, 2025
8-K Current report
Material agreement
Jan 22, 2025 Jan 21, 2025
8-K Current report
Material agreement
Jan 3, 2025 Jan 2, 2025
8-K Current report
Other events
Dec 17, 2024 Dec 13, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Other events
Oct 29, 2024 Oct 24, 2024
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 8, 2024 Oct 7, 2024
8-K Current report
Material agreement
Sep 26, 2024 Sep 23, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 20, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
Aug 2, 2024 Aug 1, 2024
8-K Current report
Other events
Jun 26, 2024 Jun 26, 2024
8-K Current report
Other events
Jun 24, 2024 Jun 20, 2024
ARS Annual report to shareholders Jun 20, 2024 Dec 31, 2023
DEF 14A Proxy statement Jun 20, 2024 Aug 1, 2024
8-K Current report
Officer or director change
Jun 10, 2024 Jun 6, 2024
8-K Current report
Officer or director change
May 13, 2024 May 10, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Other events
May 6, 2024 May 2, 2024
8-K Current report
Other events
Mar 19, 2024 Mar 14, 2024
8-K Current report
Officer or director change
Mar 18, 2024 Mar 12, 2024
8-K Current report
Material agreement, Agreement ended
Mar 18, 2024 Mar 18, 2024
424B5 Prospectus supplement Mar 18, 2024 —
10-K Annual report Mar 6, 2024 Dec 31, 2023
8-K Current report
Other events
Feb 20, 2024 Feb 20, 2024
8-K Current report
Material agreement
Jan 23, 2024 Jan 22, 2024
8-K Current report
Officer or director change
Jan 19, 2024 Jan 17, 2024
8-K Current report
Other events
Dec 21, 2023 Dec 21, 2023
8-K Current report
Officer or director change
Dec 18, 2023 Dec 18, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Material agreement, Agreement ended, Regulation FD disclosure
Sep 26, 2023 Sep 21, 2023
8-K Current report
Other events
Sep 13, 2023 Sep 11, 2023
8-K Current report
Material agreement, Other events
Aug 22, 2023 Aug 17, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Material agreement
Aug 9, 2023 Aug 7, 2023
8-K Current report
Other events
Aug 7, 2023 Aug 4, 2023
8-K Current report
Shareholder vote results
Jul 13, 2023 Jul 13, 2023
ARS Annual report to shareholders May 31, 2023 Dec 31, 2022
DEF 14A Proxy statement May 31, 2023 Jul 13, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Officer or director change
May 1, 2023 May 1, 2023
10-K Annual report Mar 6, 2023 Dec 31, 2022
8-K Current report
Bylaw or fiscal year change
Feb 27, 2023 Feb 23, 2023
8-K Current report
Other events
Jan 12, 2023 Jan 11, 2023
8-K Current report
Regulation FD disclosure
Dec 12, 2022 Dec 12, 2022
8-K Current report
Other events
Nov 14, 2022 Nov 13, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Bylaw or fiscal year change
Sep 19, 2022 Sep 15, 2022
8-K Current report
Other events
Sep 13, 2022 Sep 13, 2022
8-K Current report
Other events
Sep 8, 2022 Sep 1, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
S-8 Employee stock plan registration Jul 12, 2022 —
8-K Current report
Other events
Jul 7, 2022 Jul 7, 2022
8-K Current report
Shareholder vote results
Jun 30, 2022 Jun 30, 2022
DEF 14A Proxy statement Jun 2, 2022 Jun 30, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Officer or director change
Apr 4, 2022 Mar 30, 2022
10-QT Transition report Mar 30, 2022 Dec 31, 2021
8-K Current report
Bylaw or fiscal year change
Feb 28, 2022 Feb 28, 2022
8-K Current report
Other events
Jan 12, 2022 Jan 12, 2022
10-Q Quarterly report Jan 11, 2022 Nov 30, 2021
8-K Current report
Other events
Dec 8, 2021 Dec 7, 2021
8-K Current report
Regulation FD disclosure
Dec 7, 2021 Dec 7, 2021
10-K Annual report Nov 24, 2021 Aug 31, 2021
424B5 Prospectus supplement Nov 4, 2021 —
8-K Current report
Material agreement
Nov 4, 2021 Nov 3, 2021
8-K Current report
Other events
Oct 29, 2021 Oct 29, 2021
8-K Current report
Material agreement, Agreement ended
Sep 1, 2021 Aug 26, 2021
424B5 Prospectus supplement Sep 1, 2021 —
8-K Current report
Shareholder vote results
Aug 31, 2021 Aug 30, 2021
424B7 Filing Aug 13, 2021 —
8-K Current report
Regulation FD disclosure
Aug 5, 2021 Aug 5, 2021
8-K Current report
Other events
Aug 2, 2021 Jul 25, 2021
DEF 14A Proxy statement Jul 28, 2021 Aug 30, 2021
EFFECT Filing Jul 26, 2021 —
CORRESP Letter to the SEC Jul 22, 2021 —
UPLOAD Letter from the SEC Jul 21, 2021 —
PRE 14A Preliminary proxy statement Jul 16, 2021 Jul 16, 2021
S-3 Shelf registration Jul 15, 2021 —
8-K Current report
Material agreement, Bylaw or fiscal year change, Other events
Jul 15, 2021 Jul 14, 2021
10-Q Quarterly report Jul 14, 2021 May 31, 2021
8-K Current report
Material agreement
Jun 16, 2021 Jun 16, 2021
424B5 Prospectus supplement Jun 16, 2021 —
S-3MEF Registration statement Jun 16, 2021 —
8-K Current report
Officer or director change
May 25, 2021 May 23, 2021
8-K Current report
Officer or director change
May 10, 2021 May 6, 2021
10-Q Quarterly report Apr 13, 2021 Feb 28, 2021
8-K Current report
Other events
Mar 23, 2021 Mar 23, 2021
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Mar 19, 2021 Mar 18, 2021
EFFECT Filing Feb 10, 2021 —
UPLOAD Letter from the SEC Feb 9, 2021 —
CORRESP Letter to the SEC Feb 9, 2021 —
8-K Current report
Regulation FD disclosure
Feb 4, 2021 Feb 4, 2021
S-3 Shelf registration Feb 3, 2021 —
10-Q Quarterly report Jan 14, 2021 Nov 30, 2020
8-K Current report
Other events
Dec 2, 2020 Dec 2, 2020
8-K Current report
Material agreement
Dec 1, 2020 Dec 1, 2020
424B5 Prospectus supplement Dec 1, 2020 —
10-K Annual report Nov 24, 2020 Aug 31, 2020
8-K Current report
Regulation FD disclosure
Oct 22, 2020 Oct 22, 2020
8-K Current report
Material agreement
Sep 18, 2020 Sep 16, 2020
8-K Current report
Material agreement
Sep 9, 2020 Sep 2, 2020
8-K Current report
Material agreement
Aug 27, 2020 Aug 21, 2020
S-8 Employee stock plan registration Aug 11, 2020 —
8-K Current report
Officer or director change, Shareholder vote results, Other events
Aug 4, 2020 Aug 3, 2020
8-K Current report
Other events
Jul 15, 2020 Jul 15, 2020
10-Q Quarterly report Jul 7, 2020 May 31, 2020
DEF 14A Proxy statement Jun 30, 2020 Aug 3, 2020
PRE 14A Preliminary proxy statement Jun 16, 2020 Jun 16, 2020
CT ORDER Filing May 1, 2020 —
CT ORDER Filing May 1, 2020 —
8-K Current report
Other events
Apr 9, 2020 Apr 9, 2020
10-Q Quarterly report Apr 6, 2020 Feb 29, 2020
424B5 Prospectus supplement Mar 2, 2020 —
8-K Current report
Material agreement
Feb 28, 2020 Feb 27, 2020
424B5 Prospectus supplement Feb 26, 2020 —
8-K Current report
Other events
Feb 26, 2020 Feb 26, 2020
EFFECT Filing Feb 10, 2020 —
424B5 Prospectus supplement Feb 10, 2020 —
CORRESP Letter to the SEC Feb 6, 2020 —
UPLOAD Letter from the SEC Feb 4, 2020 —
S-3 Shelf registration Jan 31, 2020 —
10-Q Quarterly report Jan 9, 2020 Nov 30, 2019
8-K Current report
Officer or director change
Dec 6, 2019 Dec 5, 2019
10-K Annual report Nov 27, 2019 Aug 31, 2019
8-K Current report
Other events
Nov 12, 2019 Nov 12, 2019
S-8 Employee stock plan registration Oct 23, 2019 —
424B5 Prospectus supplement Sep 5, 2019 —
8-K Current report
Material agreement, Officer or director change, Shareholder vote results
Sep 5, 2019 Aug 29, 2019
8-K Current report
Officer or director change
Aug 21, 2019 Aug 18, 2019
DEF 14A Proxy statement Aug 6, 2019 Aug 29, 2019
8-K Current report
Officer or director change
Jul 29, 2019 Jul 23, 2019
10-Q Quarterly report Jul 10, 2019 May 31, 2019
8-K Current report
Officer or director change
Jul 1, 2019 Jun 25, 2019
8-K Current report
Officer or director change
May 16, 2019 May 13, 2019
8-K Current report
Agreement ended
Apr 16, 2019 Apr 12, 2019
10-Q Quarterly report Apr 10, 2019 Feb 28, 2019
8-K Current report
Officer or director change
Mar 28, 2019 Mar 25, 2019
8-K Current report
Other events
Mar 13, 2019 Mar 11, 2019
10-Q Quarterly report Jan 14, 2019 Nov 30, 2018
8-K Current report
Other events
Dec 14, 2018 Dec 11, 2018
10-K Annual report Nov 28, 2018 Aug 31, 2018
8-K Current report
Officer or director change
Nov 8, 2018 Nov 4, 2018
8-K Current report
Other events
Sep 17, 2018 Sep 17, 2018
8-K Current report
Shareholder vote results
Aug 30, 2018 Aug 28, 2018
DEF 14A Proxy statement Jul 30, 2018 Aug 28, 2018
10-Q Quarterly report Jul 12, 2018 May 31, 2018
424B5 Prospectus supplement Jul 5, 2018 —
8-K Current report
Material agreement
Jul 5, 2018 Jul 2, 2018
CT ORDER Filing Apr 16, 2018 —
10-Q Quarterly report Apr 9, 2018 Feb 28, 2018
8-K Current report
Material agreement
Feb 20, 2018 Feb 14, 2018
10-Q Quarterly report Jan 11, 2018 Nov 30, 2017
10-K Annual report Nov 29, 2017 Aug 31, 2017
424B7 Prospectus filed pursuant to rule 424(b)(7) Nov 3, 2017 —
424B7 Prospectus supplement no. 6 Oct 16, 2017 —
8-K Current report
Shareholder vote results
Sep 5, 2017 Aug 30, 2017
8-K Current report
Other events
Sep 5, 2017 Aug 31, 2017
424B7 Prospectus supplement no. 5 Aug 28, 2017 —
DEF 14A Proxy statement Aug 1, 2017 Aug 30, 2017
UPLOAD Letter from the SEC Jul 28, 2017 —
PRER14A Preliminary revised proxy soliciting materials Jul 28, 2017 —
8-K Current report
Officer or director change
Jul 21, 2017 Jul 18, 2017
PRE 14A Preliminary proxy statement Jul 20, 2017 Jul 20, 2017
10-Q Quarterly report Jul 6, 2017 May 31, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ORMP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1176309
Former names
Integrated Security Technologies, Inc. (until Apr 10, 2006); IGUANA VENTURES LTD (until Jun 10, 2004)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.